Deskripsi
Additional microbiome analysis from the berberine study reveals further compositional changes in gut bacteria associated with visceral hypersensitivity models. These data suggest berberine may modulate the microbiota-gut-brain axis in irritable bowel syndrome.
Figure 7
ChartSource Paper
Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation.Cite This Figure
![Figure 7: Additional microbiome analysis from the berberine study reveals further compositional changes in gut bacteria associated with visceral hypersensitivity models. These data suggest berberine may modulate the microbiota-gut-brain axis in irritable bowel syndrome.]() > Source: Jin-Dong Zhang et al. "Berberine alleviates visceral hypersensitivity in rats by altering gut microbiom." *Acta pharmacologica Sinica*, 2021. PMID: [33558654](https://pubmed.ncbi.nlm.nih.gov/33558654/)
<figure> <img src="" alt="Additional microbiome analysis from the berberine study reveals further compositional changes in gut bacteria associated with visceral hypersensitivity models. These data suggest berberine may modulate the microbiota-gut-brain axis in irritable bowel syndrome." /> <figcaption>Figure 7. Additional microbiome analysis from the berberine study reveals further compositional changes in gut bacteria associated with visceral hypersensitivity models. These data suggest berberine may modulate the microbiota-gut-brain axis in irritable bowel syndrome.<br> Source: Jin-Dong Zhang et al. "Berberine alleviates visceral hypersensitivity in rats by altering gut microbiom." <em>Acta pharmacologica Sinica</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33558654/">33558654</a></figcaption> </figure>